Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. White (Birmingham, United Kingdom), A. Mansur (Birmingham, United Kingdom), C. Capobianco (ParisBirmingham, United Kingdom). Clinical outcomes and micro-costing of bronchial thermoplasty in severe asthma in the UK. 4802

Member's Comments

No comment yet.

Related content which might interest you: Cost effectiveness of bronchial thermoplasty for treatment of severe asthma patients in spain Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Clinical and histological effects of Bronchial Thermoplasty in severe asthma Source: International Congress 2017 – To freeze or heat? Year: 2017 Clinical response of severe asthma patients following Bronchial Thermoplasty. Source: International Congress 2017 – To freeze or heat? Year: 2017 Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Bronchial thermoplasty for the treatment of asthma patientswith COPD characteristics: an exploratory histopathological evaluation. Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020 Thermoplasty for severe asthma Source: ERS Skills Course 2016 Year: 2016 Safety of sputum monitoring in a severe asthma population - The Manchester severe asthma team experience Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Bronchial thermoplasty as an option for severe asthma patients - our experiences and retrospective evaluation Source: International Congress 2014 – New trends in bronchoscopy: EBUS-TBNA and endoscopic treatment of emphysema Year: 2014 Predictors of good inhaler technique in asthma and COPD Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Safety of bronchial thermoplasty out to 5 years in patients with severe refractory asthma: Research in severe asthma (RISA) trial Source: Annual Congress 2011 - New treatments for airway disease Year: 2011 Real-life effectiveness of budesonide/formoterol for the management of asthma and COPD Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 Real-life evaluation of budesonide/formoterol (DuoResp Spiromax) for the management of asthma and COPD in the UK Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017 Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Real-life effectiveness of omalizumab in patients with severe persistent allergic asthma: the PERSIST study Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 The usefulness of the impulse oscillometry for predicting the treatment outcomes of bronchial thermoplasty in patients with severe asthma. Source: International Congress 2018 – Asthma analysis Year: 2018 Bronchial thermoplasty in uncontrolled severe persistent asthma. Preliminary results Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Bronchial hyperresponsiveness as a predictor of treatment-response in COPD Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Short-term effects of bronchial thermoplasty on pulmonary function in patients with severe asthma Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Efficacy of carbamazepine in treatment of bronchial asthma Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Impact of inhaler technique on patient outcomes in asthma patients using diskus in primary care Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014